According to authorities in China, a drug used in Japan to treat new strains of influenza has appeared to be effective in coronavirus patients.
An official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine turned negative for the virus after an average of four days after becoming positive, compared with an average of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
Another power outage has hit three towns on Friday morning, the 30th of May, affecting 120 homes in the Alpes-Maritimes....
Read More
France’s health minister has announced that France will introduce a nationwide ban on smoking in outdoor public areas commonly visited by children, st...
Read More
The Var department has experienced its first "tropical night" of the season, with temperatures not dropping below 25°C at 3 am, particularly in Hyères...
Read More
The Société des Bains de Mer (S.B.M.) has announced solid financial results for the 2024/2025 fiscal year, ending March 31, 2025, with revenue rising ...
Read More
France is set to experience record-breaking heat over the Ascension Day holiday, with tomorrow, Friday, May 30th, expected to be the hottest day of th...
Read More
